Anergis SA - Company & Market Research Reports

Anergis SA is a clinical-stage biopharmaceutical company that develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Anergis SA was founded in 2001 and is based in Lausanne, Switzerland.

From
Birch Pollen Allergy - Pipeline Insight, 2018 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
From
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator
adroll